Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Pioneering Oxford research to tackle vision loss is set to feature on the BBC’s One Show this week.

The BBC One programme is to feature the story of a patient from Reading who has choroideremia, a progressive loss of vision.

The patient took part in an ongoing gene therapy trial that is being performed at the John Radcliffe Hospital by the Nuffield Laboratory of Ophthalmology, led by University of Oxford Professor and OUH Consultant Ophthalmologist Robert MacLaren.

Choroideremia is a currently incurable genetic eye disorder caused by a mutation in a single gene.The new treatment seeks to replace a ‘normal’ version of that gene, offering the potential to halt or even partially reverse vision loss.

The treatment is delivered to the eye by an injection, underneath the retina, of a virus that contains the correct version of the gene. The injection places the viral particles in the correct anatomical location, and the virus itself delivers the correct copy of the gene into the dysfunctional cells.

A number of patients in this ongoing trial have already been enrolled and received gene therapy. If successful, this technique may be applied more widely to other genetic retinal diseases.

The programme is planned to broadcast on Wednesday, July 8 from 7pm.

Similar stories

Research shows how the brain reorganises old memories when new ones are made

MRC BNDU Research

Researchers have discovered that the arrangement of existing memories in the brain is altered when we embed new memories

Capturing immune cells that colonise the brain to prevent disease progression in multiple sclerosis

Clinical Neurology Research

Researchers have revealed a disease-causing population of immune cells, which travel to the brain in patients with multiple sclerosis. They demonstrate how to trap these cells in the blood, which means they can be targeted to prevent disease progression.

New machine learning system developed to identify deteriorating patients in hospital

Anaesthetics Research

Researchers have developed a machine learning algorithm that could improve clinicians’ ability to identify hospitalised patients who need intensive care.

Accidental awareness in obstetric surgery under general anaesthesia more frequent than expected

Anaesthetics Research

The largest ever study of awareness during obstetric general anaesthesia shows around 1 in 250 women may be affected, and some may experience long-term psychological harm.